Estrogen Receptor 2 (ESR2) *39 A>G
RhSafe® – Fetal RhD Factor Determination
RhSafe® is a NON-INVASIVE prenatal test that, by analyzing fetal DNA isolated from a blood sample of the pregnant woman, allows to determine the fetal Rh Factor. The test identifies pregnancies at risk for the hemolytic disease of the fetus and the newborn, and therefore reduces the use of anti-D immunoglobulins in cases where the […]
PrenatalSafe® Plus
PrenatalSafe® is a non-invasive prenatal test that analyzes circulating cell-free fetal DNA isolated from a maternal blood sample. The PrenatalSafe® Plus test detects aneuploidies of chromosomes 21, 18, 13, 9, 16 and sex chromosomes (X and Y), as well as including fetal sex determination (optional). It is also possible to detect the presence of 6 […]
Kallmann Syndrome, KAL1 (delXp22.31)
PrenatalSafe® 3
PrenatalSafe® is a non-invasive prenatal test (NIPT) based on cell-free fetal DNA analysis from maternal plasma that screens for chromosomal abnormalities in the fetus. PrenatalSafe®3 is a screening test for Trisomy 21, Trisomy 18, Trisomy 13 and fetal sex (optional). PrenatalSafe® 3 is suitable for both singleton o twin pregnancies. PrenatalSafe® 3 can be integrated, […]
Karyotype on Peripheral Blood – Couple Panel
BRCA1 and BRCA2 Rearrangements
Annexin A5 – M2 Haplotype
Cystic Fibrosis 139 mutations, Europe panel (NGS CE-IVD)
PrenatalSafe® Karyo
PrenatalSafe® is a non-invasive prenatal test that detects chromosomal abnormalities by analyzing cell-free fetal DNA from a pregnant woman’s blood sample. The PrenatalSafe® Karyo test detects aneuploidies and structural chromosomal abnormalities in the fetus on each chromosome, with results very similar to the determination of the fetal karyotype performed with invasive prenatal diagnosis procedures, as […]
